NewLimit Funding: $682M Raised, Series C (2026)

NewLimit funding overview

NewLimit is a Biotech company based in San Francisco, CA. NewLimit has raised $682M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C announced in June 2026. The round record for NewLimit runs through 2026; nothing later has been disclosed. Investors on record include Founders Fund, Kleiner Perkins, Eli Lilly, Greenoaks, Thrive Capital, Valor Equity Partners and 17 others. 23 distinct backers are named across the disclosed rounds.

NewLimit at a glance

Total raised

$682M

Latest round

Series C

Latest round date

June 2026

Industry

Biotech

Headquarters

San Francisco, CA

Notable investors

Founders Fund, Kleiner Perkins, Eli Lilly, Greenoaks, Thrive Capital, Valor Equity Partners, Nat Friedman, Daniel Gross

Frequently asked about NewLimit funding

How much has NewLimit raised?

NewLimit has raised $682M in total disclosed funding across the rounds on record.

Who has invested in NewLimit?

Founders Fund, Kleiner Perkins, Eli Lilly, Greenoaks, Thrive Capital, Valor Equity Partners are named among the investors backing NewLimit.

What was the latest NewLimit funding round?

The most recent disclosed round is a Series C, announced in June 2026.

Where is NewLimit based?

NewLimit is based in San Francisco, CA.

What sector does NewLimit operate in?

NewLimit is tracked under Biotech from San Francisco, CA, with $682M in disclosed funding.

When did NewLimit last raise?

The last disclosed NewLimit round closed in June 2026 at Series C.

We update the NewLimit record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in San Francisco and their backers are listed below.

NewLimit funding history

3 disclosed rounds on record, including 2 reported through SEC Form D filings.

1. June 2026 — Series C. $435M.
2. Filed January 2025 — Private financing. $129.8M sold of a $130M offering. 38 investors reported. SEC Form D filing
3. Filed May 2023 — Private financing. $60M sold of a $72.2M offering. 19 investors reported. SEC Form D filing

SEC Form D filings report the amount sold against a stated offering size, which can differ from press-reported round totals, and they do not name the round — those entries appear as Private financing.

Companies related to NewLimit (40)

• Crusoe Energy Systems
• Anduril Industries
• Rippling
• Affirm
• Compass
• Trade Republic
• Neuralink
• Collective Health
• Faire
• Impulse Space
• Flock Safety
• The Boring Company
• Workrise
• RigUp
• Ultima Genomics
• AbCellera
• STARK
• Solugen
• Metsera
• Revolution Medicines
• Kailera Therapeutics
• Kriya Therapeutics
• Treeline Biosciences
• 23andMe
• Beam Therapeutics
• Xaira Therapeutics
• Oruka Therapeutics
• ORIC Pharmaceuticals
• Recursion Pharmaceuticals
• Generate Biomedicines
• Odyssey Therapeutics
• Astria Therapeutics
• MapLight Therapeutics
• Mirador Therapeutics
• Colossal Biosciences
• OpenAI
• JUUL
• xAI
• Cruise
• HashiCorp

Browse related funding lists (11)

• Series C stage companies
• Startups in San Francisco
• Investors in San Francisco
• Companies that raised 500m 1b
• Companies funded in 2026
• Companies backed by Eli Lilly
• Companies backed by Founders Fund
• Companies backed by Greenoaks
• Companies backed by Kleiner Perkins
• Companies backed by Thrive Capital
• Companies backed by Valor Equity Partners

Company funding database · Investor directory · Founder database · Mega-rounds 2026